HEADER HYDROLASE 08-AUG-18 6AFP TITLE CRYSTAL STRUCTURE OF CLASS A B-LACTAMASE, PENL, VARIANT ASN136ASP, TITLE 2 FROM BURKHOLDERIA THAILANDENSIS, IN COMPLEX WITH CEFTAZIDIME-LIKE TITLE 3 BORONIC ACID COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-LACTAMASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.5.2.6; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BURKHOLDERIA THAILANDENSIS; SOURCE 3 ORGANISM_TAXID: 57975; SOURCE 4 GENE: A8H35_31635; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS EXTENDED-SPECTRUM BETA-LACTAM, ASN136ASP, PENL, BURKHODELRIA, KEYWDS 2 HYDROLASE, CEFTAZIDIME-LIKE BORONIC ACID EXPDTA X-RAY DIFFRACTION AUTHOR T.-P.CAO,J.M.CHOI,S.H.LEE REVDAT 4 22-NOV-23 6AFP 1 REMARK REVDAT 3 09-DEC-20 6AFP 1 JRNL REVDAT 2 19-FEB-20 6AFP 1 COMPND SOURCE DBREF SEQADV REVDAT 1 15-JAN-20 6AFP 0 JRNL AUTH T.-P.CAO,H.YI,I.DHANASINGH,S.GHOSH,J.M.CHOI,K.H.LEE,S.RYU, JRNL AUTH 2 H.S.KIM,S.H.LEE JRNL TITL NON-CATALYTIC-REGION MUTATIONS CONFERRING TRANSITION OF JRNL TITL 2 CLASS A BETA-LACTAMASES INTO ESBLS. JRNL REF FRONT MOL BIOSCI 2020 JRNL REFN ESSN 2296-889X JRNL DOI 10.3389/FMOLB.2020.598998 REMARK 2 REMARK 2 RESOLUTION. 1.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.79 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.560 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 3 NUMBER OF REFLECTIONS : 84284 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.150 REMARK 3 R VALUE (WORKING SET) : 0.148 REMARK 3 FREE R VALUE : 0.175 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.980 REMARK 3 FREE R VALUE TEST SET COUNT : 4199 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 27.7944 - 4.3399 0.79 2193 122 0.1797 0.1775 REMARK 3 2 4.3399 - 3.4468 0.87 2396 115 0.1409 0.1587 REMARK 3 3 3.4468 - 3.0117 0.98 2686 145 0.1405 0.1519 REMARK 3 4 3.0117 - 2.7366 1.00 2709 144 0.1474 0.1777 REMARK 3 5 2.7366 - 2.5406 1.00 2710 138 0.1490 0.1518 REMARK 3 6 2.5406 - 2.3909 1.00 2763 131 0.1442 0.1741 REMARK 3 7 2.3909 - 2.2712 1.00 2703 132 0.1438 0.1756 REMARK 3 8 2.2712 - 2.1724 1.00 2711 128 0.1363 0.1503 REMARK 3 9 2.1724 - 2.0888 1.00 2734 133 0.1378 0.1791 REMARK 3 10 2.0888 - 2.0167 1.00 2725 139 0.1397 0.1706 REMARK 3 11 2.0167 - 1.9537 1.00 2686 154 0.1368 0.1805 REMARK 3 12 1.9537 - 1.8978 1.00 2721 145 0.1425 0.1871 REMARK 3 13 1.8978 - 1.8479 1.00 2672 149 0.1423 0.1812 REMARK 3 14 1.8479 - 1.8028 1.00 2719 152 0.1482 0.2119 REMARK 3 15 1.8028 - 1.7618 1.00 2678 160 0.1481 0.1749 REMARK 3 16 1.7618 - 1.7243 1.00 2699 152 0.1507 0.1888 REMARK 3 17 1.7243 - 1.6899 1.00 2722 142 0.1559 0.2000 REMARK 3 18 1.6899 - 1.6580 1.00 2645 156 0.1480 0.1863 REMARK 3 19 1.6580 - 1.6284 1.00 2753 128 0.1475 0.1721 REMARK 3 20 1.6284 - 1.6008 1.00 2696 140 0.1485 0.1968 REMARK 3 21 1.6008 - 1.5749 1.00 2690 150 0.1478 0.1685 REMARK 3 22 1.5749 - 1.5507 1.00 2708 149 0.1477 0.1712 REMARK 3 23 1.5507 - 1.5279 0.99 2657 146 0.1524 0.1851 REMARK 3 24 1.5279 - 1.5064 1.00 2679 154 0.1585 0.1700 REMARK 3 25 1.5064 - 1.4860 1.00 2743 124 0.1554 0.2077 REMARK 3 26 1.4860 - 1.4667 1.00 2654 125 0.1625 0.2152 REMARK 3 27 1.4667 - 1.4484 0.99 2696 135 0.1655 0.2159 REMARK 3 28 1.4484 - 1.4310 0.99 2689 142 0.1743 0.2202 REMARK 3 29 1.4310 - 1.4143 0.99 2712 135 0.1784 0.2110 REMARK 3 30 1.4143 - 1.3984 0.95 2536 134 0.1828 0.2490 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.120 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 16.610 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.018 4354 REMARK 3 ANGLE : 1.853 5937 REMARK 3 CHIRALITY : 0.084 666 REMARK 3 PLANARITY : 0.011 802 REMARK 3 DIHEDRAL : 12.931 1608 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 14.1034 7.5893 17.5288 REMARK 3 T TENSOR REMARK 3 T11: 0.0976 T22: 0.1074 REMARK 3 T33: 0.1118 T12: 0.0004 REMARK 3 T13: -0.0006 T23: -0.0012 REMARK 3 L TENSOR REMARK 3 L11: 0.0866 L22: 0.1615 REMARK 3 L33: 0.2181 L12: 0.0384 REMARK 3 L13: -0.0174 L23: -0.1156 REMARK 3 S TENSOR REMARK 3 S11: -0.0042 S12: 0.0103 S13: -0.0010 REMARK 3 S21: -0.0073 S22: -0.0030 S23: -0.0154 REMARK 3 S31: -0.0008 S32: 0.0262 S33: 0.0070 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6AFP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 13-AUG-18. REMARK 100 THE DEPOSITION ID IS D_1300008678. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-DEC-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PAL/PLS REMARK 200 BEAMLINE : 5C (4A) REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97857 REMARK 200 MONOCHROMATOR : DCM SI (111) CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 84356 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.398 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 6.100 REMARK 200 R MERGE (I) : 0.08900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 36.4300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.42 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.28700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 5GL9 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 36.23 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.93 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM SODIUM ACETATE PH 5.0 200 MM REMARK 280 SODIUM CHLORIDE 25% (W/V) POLYETHYLENE GLYCOL 3350, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 46.19650 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 680 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10880 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -2.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 590 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10930 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -2.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER B 70 B CB4 B 301 1.68 REMARK 500 O HOH A 543 O HOH A 597 1.69 REMARK 500 OG SER A 70 B CB4 A 301 1.69 REMARK 500 O HOH A 543 O HOH A 580 1.99 REMARK 500 O HOH A 541 O HOH A 569 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 177 CD GLU A 177 OE2 -0.077 REMARK 500 GLY B 196 C GLY B 196 O -0.143 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 164 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 ASP A 176 CB - CG - OD1 ANGL. DEV. = 5.4 DEGREES REMARK 500 ASP A 176 CB - CG - OD2 ANGL. DEV. = -5.5 DEGREES REMARK 500 ARG A 256 NE - CZ - NH1 ANGL. DEV. = -4.1 DEGREES REMARK 500 ARG B 35 NE - CZ - NH1 ANGL. DEV. = -3.2 DEGREES REMARK 500 GLY B 196 N - CA - C ANGL. DEV. = 16.2 DEGREES REMARK 500 ARG B 256 NE - CZ - NH1 ANGL. DEV. = -3.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 69 -136.36 45.15 REMARK 500 TYR A 105 84.31 67.54 REMARK 500 ARG A 220 -125.48 -111.77 REMARK 500 CYS B 69 -136.35 44.64 REMARK 500 TYR B 105 80.71 66.51 REMARK 500 ARG B 220 -121.86 -115.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 724 DISTANCE = 5.85 ANGSTROMS REMARK 525 HOH A 725 DISTANCE = 6.23 ANGSTROMS REMARK 525 HOH A 726 DISTANCE = 8.89 ANGSTROMS REMARK 525 HOH B 685 DISTANCE = 8.34 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CB4 A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CB4 B 301 REMARK 999 REMARK 999 SEQUENCE REMARK 999 N136D IS ISOLATED FROM BACTERIAL COLONIES THAT RESISTED TO REMARK 999 ANTIBIOTIC, THUS THE MUTATION WAS NOT ACTUALLY ENGINEERED USING REMARK 999 ARTIFICIAL METHOD LIKE SITE-DIRECTED MUTAGENESIS. DBREF1 6AFP A 26 291 UNP A0A2Z4SUB5_BURTH DBREF2 6AFP A A0A2Z4SUB5 31 294 DBREF1 6AFP B 26 291 UNP A0A2Z4SUB5_BURTH DBREF2 6AFP B A0A2Z4SUB5 31 294 SEQADV 6AFP GLY A 22 UNP A0A2Z4SUB EXPRESSION TAG SEQADV 6AFP SER A 23 UNP A0A2Z4SUB EXPRESSION TAG SEQADV 6AFP HIS A 24 UNP A0A2Z4SUB EXPRESSION TAG SEQADV 6AFP MET A 25 UNP A0A2Z4SUB EXPRESSION TAG SEQADV 6AFP ASP A 136 UNP A0A2Z4SUB ASN 141 ENGINEERED MUTATION SEQADV 6AFP GLY B 22 UNP A0A2Z4SUB EXPRESSION TAG SEQADV 6AFP SER B 23 UNP A0A2Z4SUB EXPRESSION TAG SEQADV 6AFP HIS B 24 UNP A0A2Z4SUB EXPRESSION TAG SEQADV 6AFP MET B 25 UNP A0A2Z4SUB EXPRESSION TAG SEQADV 6AFP ASP B 136 UNP A0A2Z4SUB ASN 141 ENGINEERED MUTATION SEQRES 1 A 268 GLY SER HIS MET ARG ASN VAL ALA ALA GLU GLN GLN LEU SEQRES 2 A 268 ARG GLU LEU GLU SER THR PHE ASP GLY ARG LEU GLY PHE SEQRES 3 A 268 VAL ALA LEU ASP THR ALA THR GLY ALA ARG ILE ALA HIS SEQRES 4 A 268 ARG ALA ASP GLU ARG PHE PRO PHE CYS SER THR PHE LYS SEQRES 5 A 268 THR MET LEU SER ALA ALA VAL LEU ALA ARG SER ALA GLY SEQRES 6 A 268 ASP ALA ALA LEU LEU GLN ARG ARG ILE PRO TYR ALA LYS SEQRES 7 A 268 ARG ASP LEU VAL ARG TYR SER PRO ILE THR GLU LYS HIS SEQRES 8 A 268 VAL GLY ALA GLY MET THR VAL ALA GLU LEU CYS ALA ALA SEQRES 9 A 268 THR LEU GLN TYR SER ASP ASN THR ALA ALA ASP LEU LEU SEQRES 10 A 268 ILE ALA LEU LEU GLY GLY PRO GLN ALA VAL THR ALA TYR SEQRES 11 A 268 ALA ARG SER ILE GLY ASP ALA THR PHE ARG LEU ASP ARG SEQRES 12 A 268 ARG GLU THR GLU LEU ASN THR ALA ILE PRO GLY ASP GLU SEQRES 13 A 268 ARG ASP THR THR THR PRO ALA ALA MET ALA ALA SER VAL SEQRES 14 A 268 ARG ARG LEU LEU VAL GLY ASP ALA LEU GLY THR ALA GLN SEQRES 15 A 268 ARG ALA GLN LEU ASN ALA TRP MET LEU GLY ASN LYS THR SEQRES 16 A 268 GLY ASP ALA ARG ILE ARG ALA GLY VAL PRO ALA GLY TRP SEQRES 17 A 268 ARG VAL ALA ASP LYS THR GLY THR GLY ASP TYR GLY THR SEQRES 18 A 268 GLY ASN ASP ILE GLY VAL ALA TYR PRO PRO ASP ARG ALA SEQRES 19 A 268 PRO ILE VAL PHE VAL VAL TYR THR THR MET ARG SER ARG SEQRES 20 A 268 ASN ALA GLN ALA ARG ASP ASP VAL ILE ALA SER ALA ALA SEQRES 21 A 268 ARG ILE ALA ALA ARG ALA PHE VAL SEQRES 1 B 268 GLY SER HIS MET ARG ASN VAL ALA ALA GLU GLN GLN LEU SEQRES 2 B 268 ARG GLU LEU GLU SER THR PHE ASP GLY ARG LEU GLY PHE SEQRES 3 B 268 VAL ALA LEU ASP THR ALA THR GLY ALA ARG ILE ALA HIS SEQRES 4 B 268 ARG ALA ASP GLU ARG PHE PRO PHE CYS SER THR PHE LYS SEQRES 5 B 268 THR MET LEU SER ALA ALA VAL LEU ALA ARG SER ALA GLY SEQRES 6 B 268 ASP ALA ALA LEU LEU GLN ARG ARG ILE PRO TYR ALA LYS SEQRES 7 B 268 ARG ASP LEU VAL ARG TYR SER PRO ILE THR GLU LYS HIS SEQRES 8 B 268 VAL GLY ALA GLY MET THR VAL ALA GLU LEU CYS ALA ALA SEQRES 9 B 268 THR LEU GLN TYR SER ASP ASN THR ALA ALA ASP LEU LEU SEQRES 10 B 268 ILE ALA LEU LEU GLY GLY PRO GLN ALA VAL THR ALA TYR SEQRES 11 B 268 ALA ARG SER ILE GLY ASP ALA THR PHE ARG LEU ASP ARG SEQRES 12 B 268 ARG GLU THR GLU LEU ASN THR ALA ILE PRO GLY ASP GLU SEQRES 13 B 268 ARG ASP THR THR THR PRO ALA ALA MET ALA ALA SER VAL SEQRES 14 B 268 ARG ARG LEU LEU VAL GLY ASP ALA LEU GLY THR ALA GLN SEQRES 15 B 268 ARG ALA GLN LEU ASN ALA TRP MET LEU GLY ASN LYS THR SEQRES 16 B 268 GLY ASP ALA ARG ILE ARG ALA GLY VAL PRO ALA GLY TRP SEQRES 17 B 268 ARG VAL ALA ASP LYS THR GLY THR GLY ASP TYR GLY THR SEQRES 18 B 268 GLY ASN ASP ILE GLY VAL ALA TYR PRO PRO ASP ARG ALA SEQRES 19 B 268 PRO ILE VAL PHE VAL VAL TYR THR THR MET ARG SER ARG SEQRES 20 B 268 ASN ALA GLN ALA ARG ASP ASP VAL ILE ALA SER ALA ALA SEQRES 21 B 268 ARG ILE ALA ALA ARG ALA PHE VAL HET CB4 A 301 22 HET ACT A 302 4 HET CB4 B 301 22 HETNAM CB4 PINACOL[[2-AMINO-ALPHA-(1-CARBOXY-1-METHYLETHOXYIMINO)- HETNAM 2 CB4 4-THIAZOLEACETYL]AMINO]METHANEBORONATE HETNAM ACT ACETATE ION FORMUL 3 CB4 2(C10 H15 B N4 O6 S) FORMUL 4 ACT C2 H3 O2 1- FORMUL 6 HOH *611(H2 O) HELIX 1 AA1 SER A 23 SER A 39 1 17 HELIX 2 AA2 THR A 71 ALA A 85 1 15 HELIX 3 AA3 ALA A 98 LEU A 102 5 5 HELIX 4 AA4 ILE A 108 VAL A 113 5 6 HELIX 5 AA5 VAL A 119 SER A 130 1 12 HELIX 6 AA6 ASP A 131 GLY A 143 1 13 HELIX 7 AA7 GLY A 144 ILE A 155 1 12 HELIX 8 AA8 THR A 167 THR A 171 5 5 HELIX 9 AA9 THR A 182 VAL A 195 1 14 HELIX 10 AB1 LEU A 199 GLY A 213 1 15 HELIX 11 AB2 ARG A 220 VAL A 225 5 6 HELIX 12 AB3 ARG A 275 VAL A 291 1 17 HELIX 13 AB4 SER B 23 SER B 39 1 17 HELIX 14 AB5 THR B 71 SER B 84 1 14 HELIX 15 AB6 ALA B 89 GLN B 92 5 4 HELIX 16 AB7 ALA B 98 LEU B 102 5 5 HELIX 17 AB8 ILE B 108 VAL B 113 5 6 HELIX 18 AB9 VAL B 119 TYR B 129 1 11 HELIX 19 AC1 ASP B 131 GLY B 143 1 13 HELIX 20 AC2 GLY B 144 ILE B 155 1 12 HELIX 21 AC3 THR B 167 THR B 171 5 5 HELIX 22 AC4 THR B 182 VAL B 195 1 14 HELIX 23 AC5 GLY B 200 GLY B 213 1 14 HELIX 24 AC6 ARG B 220 VAL B 225 1 6 HELIX 25 AC7 ARG B 275 VAL B 291 1 17 SHEET 1 AA1 5 ARG A 57 HIS A 60 0 SHEET 2 AA1 5 GLY A 43 ASP A 51 -1 N PHE A 47 O HIS A 60 SHEET 3 AA1 5 ILE A 259 MET A 267 -1 O TYR A 264 N GLY A 46 SHEET 4 AA1 5 THR A 243 TYR A 251 -1 N ALA A 250 O ILE A 259 SHEET 5 AA1 5 ARG A 230 GLY A 238 -1 N GLY A 236 O ASN A 245 SHEET 1 AA2 2 PHE A 66 PRO A 67 0 SHEET 2 AA2 2 THR A 180 THR A 181 -1 O THR A 181 N PHE A 66 SHEET 1 AA3 2 ARG A 94 TYR A 97 0 SHEET 2 AA3 2 GLY A 114 THR A 118 -1 O GLY A 114 N TYR A 97 SHEET 1 AA4 5 ARG B 57 HIS B 60 0 SHEET 2 AA4 5 GLY B 43 ASP B 51 -1 N PHE B 47 O HIS B 60 SHEET 3 AA4 5 ILE B 259 MET B 267 -1 O TYR B 264 N GLY B 46 SHEET 4 AA4 5 THR B 243 TYR B 251 -1 N GLY B 248 O PHE B 261 SHEET 5 AA4 5 ARG B 230 GLY B 238 -1 N GLY B 236 O ASN B 245 SHEET 1 AA5 2 PHE B 66 PRO B 67 0 SHEET 2 AA5 2 THR B 180 THR B 181 -1 O THR B 181 N PHE B 66 SHEET 1 AA6 2 ARG B 94 TYR B 97 0 SHEET 2 AA6 2 GLY B 114 THR B 118 -1 O GLY B 114 N TYR B 97 CISPEP 1 GLU A 166 THR A 167 0 9.20 CISPEP 2 GLU B 166 THR B 167 0 7.09 SITE 1 AC1 17 CYS A 69 SER A 70 TYR A 105 ASN A 132 SITE 2 AC1 17 GLU A 166 LEU A 169 ASN A 170 ARG A 192 SITE 3 AC1 17 ASP A 197 GLY A 236 THR A 237 GLY A 238 SITE 4 AC1 17 ASP A 240 HOH A 417 HOH A 453 HOH A 580 SITE 5 AC1 17 HOH A 646 SITE 1 AC2 6 ALA A 82 ARG A 104 ALA A 198 HOH A 451 SITE 2 AC2 6 HOH A 626 HOH A 703 SITE 1 AC3 20 CYS B 69 SER B 70 ARG B 104 TYR B 105 SITE 2 AC3 20 SER B 130 ASN B 132 ASN B 170 ARG B 192 SITE 3 AC3 20 GLY B 196 ASP B 197 GLY B 236 THR B 237 SITE 4 AC3 20 GLY B 238 ASP B 240 HOH B 407 HOH B 412 SITE 5 AC3 20 HOH B 415 HOH B 456 HOH B 536 HOH B 670 CRYST1 34.883 92.393 68.841 90.00 94.27 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.028667 0.000000 0.002138 0.00000 SCALE2 0.000000 0.010823 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014567 0.00000